Literature DB >> 10900091

Growth factor regulation of the cell cycle in developing and mature inner ear sensory epithelia.

E C Oesterle1, C R Hume.   

Abstract

Growth factors and other extracellular signals regulate cell division in many tissues. Consequently, growth factors may have therapeutic uses to stimulate the production of replacement sensory hair cells in damaged human inner ears, thereby assisting in alleviating hearing loss and vestibular dysfunction. Assessment of the ability of growth factors to stimulate cell proliferation in inner ear sensory epithelia is at an early stage. This paper provides a brief account of what we know regarding growth factor regulation of cell proliferation in developing and mature inner ear sensory epithelia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10900091     DOI: 10.1023/a:1007074222659

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  5 in total

Review 1.  Concise review: Inner ear stem cells--an oxymoron, but why?

Authors:  Mohammad Ronaghi; Marjan Nasr; Stefan Heller
Journal:  Stem Cells       Date:  2012-01       Impact factor: 6.277

Review 2.  Regulated reprogramming in the regeneration of sensory receptor cells.

Authors:  Olivia Bermingham-McDonogh; Thomas A Reh
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

Review 3.  [Regenerative medicine in the treatment of sensorineural hearing loss].

Authors:  H Löwenheim; J Waldhaus; B Hirt; S Sandke; M Müller
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

Review 4.  A brief history of hair cell regeneration research and speculations on the future.

Authors:  Edwin W Rubel; Stephanie A Furrer; Jennifer S Stone
Journal:  Hear Res       Date:  2013-01-12       Impact factor: 3.208

5.  ErbB expression: the mouse inner ear and maturation of the mitogenic response to heregulin.

Authors:  Clifford R Hume; Mette Kirkegaard; Elizabeth C Oesterle
Journal:  J Assoc Res Otolaryngol       Date:  2003-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.